Dermavir (GIC)

Dermavir (GIC) widget

ICO date: 15.05.2018 - 30.05.2018
Product Type: Technology
Industry: Drugs & Healthcare

Dermavir is a Dendritic Cell-Targeting Therapeutic Vaccine Technology Platform.


Therapeutic Vaccine for treatment of HIV, referred to as “DermaVir”, is effective in boosting immune response which kills HIV-infected cells. Human clinical trials have demonstrated vaccine is capable of killing HIV-infected cells. DermaVir has a safety profile similar to vaccines used in healthy adults and children. DermaVir can also be a co-treatment option if administered with antiretroviral therapy.

Founded: Hungary, 1988
Whitepaper: Whitepaper

Rating Review and Analytics

Investment rating
Hype score
Very Low 1.0 / 5.0
Risk score

Other projects

Startup name Start-end ICO Hype Score Risk Score Rating Industry
HPlus (H+) 13.01.2018 - 30.05.2018
Drugs & Healthcare
CryoGen (CRYO) 01.02.2018 - 01.07.2018
Drugs & Healthcare
Clinicoin (CLIN) 20.02.2018 - 31.05.2018
Drugs & Healthcare
HorseCoin (HRC) 24.02.2018 - 29.06.2018
Drugs & Healthcare

See also